Loading insider details...
Beta
Latest Form 4 (Aug 24, 2026): Purchase of 20,000 PTIX shares, $13.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 20,000 | $13.0K |
| Aug 21, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 16,634 | $9.8K |
| Aug 20, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 2,700 | $945.00 |
| Aug 13, 2026 | AGENUS INC (AGEN) | Grant/Award | 1,971,500 | n/a |
| Aug 12, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 2,220 | $710.40 |
| Aug 10, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 685 | $150.70 |
| Aug 7, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 5,000 | $1.3K |
| Aug 3, 2026 | Protagenic Therapeutics, Inc.\new (PTIX) | Purchase | 26,291 | $4.8K |
| Jul 14, 2026 | AGENUS INC (AGEN) | Grant/Award | 4,852 | $16.3K |
| Jun 30, 2026 | AGENUS INC (AGEN) | Grant/Award | 5,364 | $16.3K |